In this regard, increased levels of miR-146a were reported in PBMCs from SS patients, which has particular importance as it regulates the innate immune and inflammatory response by repressing IRAK1 and increasing TRAF6 gene expression, which promotes the expression of NF-κB target genes [99]. This evidence concerns the gene TRAF6 and synovial sarcoma.